Citation: | WU Jie, WANG Huan, LIANG Changping, WANG Min, HE Tao. Value of serum stimulant thyroglobulin level in the diagnosis and predicting prognosis of differentiated thyroid carcinoma[J]. Journal of Clinical Medicine in Practice, 2021, 25(10): 57-61. DOI: 10.7619/jcmp.20210124 |
[1] |
XU N, CHEN J, HE G, et al. Prognostic values of m6A RNA methylation regulators in differentiated Thyroid Carcinoma[J]. J Cancer, 2020, 11(17):5187-5197. doi: 10.7150/jca.41193
|
[2] |
DELIGIORGI M V, PANAYIOTIDIS M I, TRAFALIS D T. Prophylactic lymph node dissection in clinically N0 differentiated thyroid carcinoma:example of personalized treatment[J]. Pers Med, 2020, 17(4):317-338. doi: 10.2217/pme-2019-0119
|
[3] |
JACOMINA L E, JACINTO J K M, CO L B A, et al. The Role of postoperative external beam radiotherapy for differentiated thyroid carcinoma:a Systematic review and meta-analysis[J]. Head Neck, 2020, 42(8):2181-2193. doi: 10.1002/hed.26133
|
[4] |
SUZUKI H, NISHIKAWA D, BEPPU S, et al. Prognostic value of age and distant metastasis in differentiated thyroid carcinoma undergoing salvage surgery[J]. Anticancer Res, 2020, 40(2):1127-1133. doi: 10.21873/anticanres.14053
|
[5] |
王任飞, 高再荣, 欧阳伟, 等.分化型甲状腺癌转移灶摄碘能力与131Ⅰ清灶疗效关系的回顾性多中心研究[J].中华核医学与分子影像杂志, 2020, 40(6):334-338. doi: 10.3760/cma.j.cn321828-20200220-00059
|
[6] |
TAMAM M, UYANIK E, EDÍS N, et al. Differentiated thyroid carcinoma in children:Clinical characteristics and long-term follow-up[J]. World J Nucl Med, 2020, 19(1):28-35. doi: 10.4103/wjnm.WJNM_15_19
|
[7] |
HARRIES V, MCGILL M, TUTTLE R M, et al. Management of retropharyngeal lymph node metastases in differentiated thyroid carcinoma[J]. Thyroid, 2020, 30(5):688-695. doi: 10.1089/thy.2019.0359
|
[8] |
JIANG H J, HSIAO P J. Clinical application of the ultrasound-guided fine needle aspiration for thyroglobulin measurement to diagnose lymph node metastasis from differentiated thyroid carcinoma-literature review[J]. Kaohsiung J Med Sci, 2020, 36(4):236-243. doi: 10.1002/kjm2.12173
|
[9] |
刘杰蕊, 刘延晴, 李慧, 等.动态危险度评估在中高危无远处转移性分化型甲状腺癌患者随访中的意义[J].中国医学科学院学报, 2020, 42(2):222-227. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYKX202002012.htm
|
[10] |
刘欣迪, 周青, 朱远, 等.甲状腺乳头状癌患者首次131Ⅰ治疗前刺激性Tg与TSH比值与最佳治疗反应的关系[J].现代肿瘤医学, 2020, 28(10):1646-1651. doi: 10.3969/j.issn.1672-4992.2020.10.008
|
[11] |
武标, 徐慧琴, 汪会, 等.低水平sTg与甲状腺乳头状癌131Ⅰ治疗后临床转归的关系[J].安徽医科大学学报, 2020, 55(4):602-606. https://www.cnki.com.cn/Article/CJFDTOTAL-YIKE202004023.htm
|
[12] |
ZANELLA A, SCHEFFEL R S, PASA M W, et al. Role of postoperative stimulated thyroglobulin as prognostic factor for differentiated thyroid cancer in children and adolescents[J]. Thyroid, 2017, 27(6):787-792. doi: 10.1089/thy.2016.0559
|
[13] |
王兴, 李伟文, 邵明涛, 等.分化型甲状腺癌中央区淋巴结转移患者临床病理特征及转移危险因素分析[J].肿瘤研究与临床, 2020, 32(7):493-497. doi: 10.3760/cma.j.cn115355-20190731-00335
|
[14] |
黄俊伟, 段翰源, 高文, 等.分化型甲状腺癌高细胞亚型的临床特征分析[J].中国耳鼻咽喉头颈外科, 2020, 27(5):235-238. https://www.cnki.com.cn/Article/CJFDTOTAL-EBYT202005001.htm
|
[15] |
卢承慧, 李娇, 刘新峰, 等.治疗前刺激性甲状腺球蛋白阴性合并淋巴结转移的分化型甲状腺癌131Ⅰ治疗后的临床转归[J].中国癌症杂志, 2019, 29(6):429-433. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGAZ201906007.htm
|
[16] |
彭庆, 郑容.刺激性甲状腺球蛋白预测分化型甲状腺癌转移及其影响因素研究进展[J].中国医学影像技术, 2019, 35(9):1414-1417. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYXX201909044.htm
|